P073: Phase 1b study of ARN-509 with abiraterone acetate and prednisone in patients with metastatic Castration-Resistant Prostate Cancer (mCRPC)Posadas E.¹, Chi K.N.², De Wit R.³, De Jonge M.J.A.³, Attard G.⁴, Friedlander T.⁵, Yu M.K.⁶, Hellemans P.⁷, Chien C.⁸, Abrams C.⁹, Gonzalez M.¹⁰, Trudel G.C.⁶, Chauhan V.¹¹, Jiao J.¹¹, Saad F.¹²

12 Nov 2015

349

EP168: Evaluation of chemotherapy response in seminomasCosta A.L.¹, Abreu C.¹, Pacheco T.¹, Ortega A.², Mulet N.², Jimenez L.², Piulats J.M.², Quintela A.¹, Costa L.¹, Garcia Del Muro X.²

12 Nov 2015

379

EP168:

12 Nov 2015

351

EP177: Tumour size in MRI and percentage of cancer in biopsy are independent predictors of side-specific pathologic T3 prostate cancerDybowski B.¹, Bres-Niewada E.¹, Lorenc T.², Powała A.³, Borkowski T.¹, Radziszewski P.¹

12 Nov 2015

432

P143: Treatment of renal cell carcinoma of native kidney in kidney transplantationLedo Cepero M.J., Parra Servan P., Ojeda A.V., León Delgado C., Rosety Rodriguez J., Amores Bermúdez J., Cañete Bermúdez J., Pérez-Lanzac A., Alvarez-Ossorio Fernández J.L

12 Nov 2015

298